Correlation of glycated haemoglobin status with the foot ulcer
DOI:
https://doi.org/10.18203/2349-2902.isj20232637Keywords:
Glycated hemoglobin, Foot ulcer, DiabetesAbstract
Background: Diabetic foot ulcer is a well-documented complication of uncontrolled diabetes and its association with the variables involved in Diabetes like FBS, RBS and HBA1C has been thoroughly researched. This research aims to identify the association of diabetic foot ulcer under Wagner classification with HBA1C classes. Objectives were to determine the severity of diabetic foot ulcer at various level of HBA1C and determine the association.
Methods: A observational cross-sectional study with 160 diabetic patients who after giving consent filled questionnaires. The information was analyzed using SPSS v26 (IBM) through Chi Square test. The results were tabulated and inferred from.
Results: The study included Sample size of 160 Patients. Here in the study mean age for group A was 41.2 years, for group B it was 29.6 years and for group C it was 25.8 years. Majority 40% patients in group A had T2DM. In group B we found that 51.7% patients had T2DM followed by 48.2% patients with T1DM. In group C we found that majority 67.01% patients had T2DM. We found that site of ulcer was improving with increasing duration of follow up. Initially we found 30% patients with infection at dorsum aspect of foot. After follow up day 9 we found improvement in ulcer infection
Conclusions: This research further supplemented an already strongly established association between uncontrolled diabetes and diabetic foot ulcer. We focused on specifically HBA1C and how increased lab values are linked with different grades of Diabetic Foot ulcer and found a strong association demanding a proactive approach towards patient care and education. HbA1c has a linear relationship with the grades of Wagner classification of diabetic foot.
References
Hussain A, Ali I, Ijaz M. Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia. Ther Adv Endocrinol Metab. 2017;8:51-7.
Diabetes Available at: http://www.diabetesatlas. org/. Accessed on 8 August 2019.
Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V. India diabetes study: methodological details. J Diabetes Sci Technol. 2011;5(4):906-14.
Reiber GE. Epidemiology of foot ulcers and amputations in the diabetic foot. In: Bowker JH, Pfeifer MA (eds). St. Louis: Mosby; 13-32.
Laing P. The development and complications of diabetic foot ulcers. Am J Surg. 1998;176(2):11-19.
Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O'Brien PC, Melton LJ 3rd, Service FJ. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817-24.
Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521-34.
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69: 89-95.
Boulton AJ. Management of Diabetic Peripheral Neuropathy. Clin Diab. 2005;23:9-15.
Oyibo SO, Prasad YD, Jackson NJ, Jude EB, Boulton AJ. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med. 2002;19(10):870-3.
Katoulis EC, Ebdon-Parry M, Lanshammar H, Vileikyte L, Kulkarni J, Boulton AJ. Gait abnormalities in diabetic neuropathy. Diabetes Care. 1997;20(12):1904-7.
Boulton AJM, Kirsner RS, Vileikyte L. Neuropathic Diabetic Foot Ulcers. N Engl J Med. 2004;351:48-55.
Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19(5):377-84.
Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg. 2006;108(5):477-81.
Shahzad M, Al Robaee A, Al Shobaili HA, Alzolibani AA, Al Marshood AA, Al Moteri B. Skin manifestations in diabetic patients attending a diabetic clinic in the Qassim region, Saudi Arabia. Med Princ Pract. 2011;20(2):137-41.
Carrington AL, Shaw JE, Van SCH. Can Motor Nerve Conduction Velocity Predict Foot Problems in Diabetic Subjects Over a 6-Year Outcome Period?. Diabetes Care. 2002;25:2010-5.
Xu F, Zhao LH, Su JB, Chen T, Wang XQ, Chen JF, Wu G, Jin Y, Wang XH. The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetol Metab Syndr. 2014;6(1):139.
Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain. 2000; 123(12):2542-51.
American Diabetes Association. Standards of Medical Care in Diabetes 2017 Abridged for Primary Care Providers. Clin Diab. 2016;35:5-26.
Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, et al. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008;93:2447-53.
Boulton AJM. The global burden of diabetic. Lancet. 2005;366:1719-24.
Li X, Xiao T, Wang Y, Gu H, Liu Z, Jiang Y, Liu Y, Lu Z, Yang X, Lan Y, Xu Z. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital. Diabetes Res Clin Pract. 2011;93(1):26-30.
Stettler C, Allemann S, Juni P. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J. 2006;152:27-38.
Levin ME. Preventing amputation in the patient with diabetes. Diabetes Care. 1995;18:1383-94.
Apelqvist J, Larsson J, Agardh CD. The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers. J Diabet Complicat. 2009;4:21-5.
Aamir AH, Nasir A, Jadoon MZ, Mehmood K, Ali SS. Diabetic foot infections and their management in a tertiary care hospital. J Ayub Med Coll Abottabad. 2011;23:58-62.
Hasan F, Rana HN, Ali M, Tahir M, Saleem R. Diabetic foot - assessment and management of 100 cases. Pak J Med Health Sci. 2011;5:677-81.
Ashraf MN, Rehman K, Malik KI, Iqbal GS. Epidemiology and outcome in patients of diabetic foot. J Ayub Med Coll Abottabad. 2011;23:122-4.
Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366(9498):1736-43.
Fesseha BK, Abularrage CJ, Hines KF. Association of hemoglobin A1c and wound healing in diabetic foot ulcers. Diab Care. 2018;41(7):1478-85.
Vinod R, Gyawali P, Raut PP, Regmi P, Singh KP, Pandeya DR, et al. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: Glycated haemoglobin as a dual biomarker. Biomedical Res. 2011;22(3):32-9.
Mostafa S, Coleman R, Agbaje O, Gray A, Holman R, Bethel M. Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease. Diab Med. 2018;35(1):72-7.
Christman AL, Selvin E, Margolis DJ, Lazarus GS, Garza LA. Hemoglobin A1c predicts healing rate in diabetic wounds. J Invest Dermatol. 2011;131(10): 2121-7.
Ahmed AA. Epidemiology of diabetes mellitus and diabetic foot problems in Saudi Arabia. Avan Diab. 2010;29:29-35.
Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet. 2003;361:1545-51.
Monteiro-Soares M, Ribas R, Pereira da Silva C, Bral T, Mota A, Pinheiro Torres S, et al. Diabetic foot ulcer development risk classifications’ validation: A multicentre prospective cohort study. Diab Res Clin Pract. 2017;127:105-14.
Joshi SR, Parikh RM. India-diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India. 2007;55:323-4.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes-estimates for the year 2000 and projections for 2030. Diab Care. 2004;27(3):1047-53.
Whiting Dr, Guariguata L, Weil C, Shawj. IDF Diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diab Res Clin Pract. 2011;94:311-21.
Anjana RM, Ali MK, Pradeepa R, Deepa M, Datta M, Unnikrishnan R, Rema M, Mohan V. The need for obtaining accurate nationwide estimates of diabetes prevalence in India - rationale for a national study on diabetes. Indian J Med Res. 2011;133:369-80.
Zargar AH, Khan AK, Masoodi SR, Laway BA, Wani AI, Bashir MI, Dar FA. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent. Diab Res Clin Pract. 2000;47(2):135-46.
Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, Rao PV, Yajnik CS, Prasanna Kumar KM, Nair JD; Diabetes Epidemiology Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001;44(9): 1094-101.
Diabetes Foot Ulcer. Available at: https://els-jbs-prod-cdn.jbs.cms/attachment/9b1b5ad3-cc86-4eea-bca4-c224fd53daa7/gr6_lrg.jpg. Accessed on 20 February 2022.
Bramley D, Hebert P, Jackson R, Chassin M. Indigenous disparities in disease‐specific mortality, a cross‐country comparison: New Zealand, Australia, Canada, and the United States. Nz Med J. 2004; 117(1207):U1215.
Khalil H, George J. Diabetes management in Australian rural aged care facilities: A cross-sectional audit. Australas Med J. 2012;5(11):575‐80.
Rao CR, Kamath VG, Shetty A, Kamath A. A crosssectional analysis of obesity among a rural population in coastal southern Karnataka, India. Australas Med J. 2011;4(1):53-7.
Misra A, Khurana L. Obesity-related non-communicable diseases: South Asians vs White Caucasians. Int J Obes. 2011;35(2):167-87.
Mohan V, Shah S, Saboo B. Current glycemic status and diabetes related complications among type 2 diabetes patients in India: data from the A1chieve study. JAPI. 2013;61:12-15.
Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai urban rural Epidemiology Study (CurES) Eye Study. Invest Ophthalmol Vis Sci. 2005;46:2328-33.
Iyer SN, Drake AJ, West RL, Tanenberg RJ. Diabetic muscle infarction: a rare complication of long-standing and poorly controlled diabetes mellitus. Case Rep Med. 2011;2011:407921.
